The Chemours Company (CC)
NYSE: CC · Real-Time Price · USD
13.09
-0.07 (-0.53%)
Nov 3, 2026, 4:00 PM EST - Market closed
The Chemours Company Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,970 | 1,767 | 2,525 | 4,682 | 4,621 | 5,469 | |
Market Cap Growth | -1.72% | -30.01% | -46.07% | 1.31% | -15.50% | 34.11% |
Enterprise Value | 5,297 | 5,575 | 6,221 | 8,061 | 7,229 | 8,518 |
Last Close Price | 13.09 | 11.62 | 16.05 | 28.66 | 26.90 | 28.61 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | 36.60 | - | 8.00 | 8.99 |
Forward PE | 8.12 | 8.24 | 8.41 | 9.56 | 9.17 | 7.59 |
PS Ratio | 0.34 | 0.30 | 0.44 | 0.77 | 0.68 | 0.86 |
PB Ratio | 12.71 | 7.04 | 4.41 | 6.34 | 4.17 | 5.05 |
P/TBV Ratio | 18.41 | 8.75 | 4.84 | 7.41 | 4.66 | 5.62 |
P/FCF Ratio | 9.34 | 34.65 | - | 25.17 | 10.32 | 10.18 |
P/OCF Ratio | 4.93 | 6.69 | - | 8.42 | 6.12 | 6.72 |
PEG Ratio | - | 2.53 | 2.53 | 2.53 | 0.75 | 0.22 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.91 | 0.96 | 1.08 | 1.33 | 1.06 | 1.34 |
EV/EBITDA Ratio | 9.94 | 8.75 | 8.80 | 31.37 | 6.67 | 8.45 |
EV/EBIT Ratio | 24.87 | 18.77 | 14.99 | - | 9.12 | 12.33 |
EV/FCF Ratio | 25.10 | 109.32 | - | 43.34 | 16.14 | 15.86 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 25.80 | 17.51 | 7.64 | 5.82 | 3.51 | 3.69 |
Debt / EBITDA Ratio | 5.82 | 5.72 | 5.45 | 12.46 | 3.36 | 3.62 |
Debt / FCF Ratio | 19.08 | 86.16 | - | 23.11 | 8.66 | 7.43 |
Net Debt / Equity Ratio | 21.33 | 14.84 | 6.39 | 4.19 | 2.51 | 2.34 |
Net Debt / EBITDA Ratio | 6.24 | 5.85 | 5.17 | 12.05 | 2.56 | 2.52 |
Net Debt / FCF Ratio | 15.77 | 73.02 | -3.68 | 16.65 | 6.20 | 4.72 |
Asset Turnover | 0.79 | 0.78 | 0.73 | 0.77 | 0.90 | 0.87 |
Inventory Turnover | 3.28 | 3.23 | 3.30 | 3.44 | 4.17 | 4.87 |
Quick Ratio | 0.91 | 0.80 | 0.81 | 0.73 | 0.91 | 1.17 |
Current Ratio | 1.81 | 1.78 | 1.66 | 1.54 | 1.70 | 1.80 |
Return on Equity (ROE) | -67.98% | -93.80% | 10.53% | -27.30% | 52.81% | 64.10% |
Return on Assets (ROA) | 1.79% | 2.49% | 3.29% | -0.41% | 6.53% | 5.90% |
Return on Invested Capital (ROIC) | -5.66% | 7.24% | 6.70% | -1.35% | 16.49% | 16.34% |
Return on Capital Employed (ROCE) | 3.90% | 5.20% | 7.30% | -0.90% | 13.80% | 12.10% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -7.79% | -21.84% | 2.73% | -5.40% | 12.51% | 11.12% |
FCF Yield | 10.71% | 2.89% | -39.33% | 3.97% | 9.70% | 9.82% |
Dividend Yield | 2.67% | 4.35% | 5.92% | 3.17% | 3.21% | 2.94% |
Payout Ratio | - | - | 214.49% | - | 26.64% | 26.97% |
Buyback Yield / Dilution | -0.58% | -0.04% | -0.85% | 5.93% | 6.16% | -1.41% |
Total Shareholder Return | 2.09% | 4.30% | 5.07% | 9.11% | 9.38% | 1.53% |